Sign In
Buy CUE
$26.91
-1.71 (-5.97%)
At Close: Jun 03, 2026
Vident Investment Advisory LLC Acquires New Stake in Cue Biopharma Inc (NASDAQ:CUE)
07:42am, Monday, 03'rd Aug 2020
Vident Investment Advisory LLC bought a new position in Cue Biopharma Inc (NASDAQ:CUE) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bough
Morgan Stanley Has $556,000 Stock Position in Cue Biopharma Inc (NASDAQ:CUE)
04:48am, Monday, 03'rd Aug 2020
Morgan Stanley lessened its stake in Cue Biopharma Inc (NASDAQ:CUE) by 48.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional
* CUE-101 advances to cohort 5 following Safety Review Committee assessment of expanded cohort 4 * Cohort 5 is fully enrolled, with first patient having been dosed on July 20 * Additional patients
Third Federal Savings and Loan Association of Cleveland, MHC Members Approve Dividend Waiver
12:00am, Tuesday, 14'th Jul 2020
At today’s special meeting of members of Third Federal Savings and Loan Association of Cleveland, MHC, the mutual holding company and 81% majority sha
- Novel insights into receptor binding events and interfaces have led to generation of selective molecules with unique biochemical and functional properties through an effort.
Here's What Cue Biopharma, Inc.'s (NASDAQ:CUE) Shareholder Ownership Structure Looks Like
06:36pm, Monday, 06'th Jul 2020
Every investor in Cue Biopharma, Inc. (NASDAQ:CUE) should be aware of the most powerful shareholder groups. Large...
Nuveen Asset Management LLC Sells 44,220 Shares of Cue Biopharma Inc (NASDAQ:CUE)
05:14am, Monday, 06'th Jul 2020
Nuveen Asset Management LLC lessened its position in shares of Cue Biopharma Inc (NASDAQ:CUE) by 33.8% during the first quarter, according to its most recent filing with the Securities and Exchange Co
Hedge Funds Have Never Been This Bullish On Cue Biopharma, Inc. (CUE)
01:12am, Sunday, 28'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Politics and Policy: Drug firms called to embrace concept of public goods
08:00am, Thursday, 18'th Jun 2020
AN experimental drug for Covid-19 has put the spotlight on barriers to treatment for millions of people on the basis of marketing decisions by pharmaceutical companies. Malaysia has been excluded from
From hockey poster boy to forlorn star
09:43am, Wednesday, 17'th Jun 2020
Faizal Saari is still devastated over his exclusion from the “Speedy Tigers” in February, and the continuing criticism by the Malaysian Hockey Confederation (MHC).
Cue Biopharma Provides Update on Ongoing Phase 1 Trial Evaluating CUE-101 in Recurrent/Metastatic Head and Neck Cancer
12:00pm, Monday, 15'th Jun 2020
Cue Biopharma, Inc. (CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted T cells within the body, is
Cue Health raises $100M to validate at-home flu test
09:22pm, Wednesday, 10'th Jun 2020
Cue Health, a startup developing a connected testing device, closed a $100 million series C round. The company recently submitted its system to the FDA for emergency use authorization to be used for o
Cue Biopharma to Present Corporate Overview and Pipeline Progress at Jefferies Virtual Healthcare Conference
12:00pm, Thursday, 28'th May 2020
Cue Biopharma, Inc. (CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body, announced t
The Daily Biotech Pulse: FDA Nod For Aquestive, Tetraphase M&A Plot Thickens, Amarin's Vascepa In COVID Fray
12:00am, Friday, 22'nd May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 21)
ADC Therapeutics SA (NYSE:...
Cue Biopharma, Inc. (CUE) Q1 2020 Earnings Call Transcript
01:01am, Thursday, 21'st May 2020
Greetings, and welcome to Cue Biopharma first-quarter 2020 earnings call. It is now my pleasure to introduce your host Ashley Robinson, investor relations. This is Ashley from LifeSci Advisors, and
